The Challenges and Advantages of Decentralized Clinical Trials in an era of increasing complexities

Nate Hughes, MPH, MPP, M. Phil. Johns Hopkins Bloomberg School of Public Health Alumnus  A recent survey from Applied Clinical Trials noted that 76% of 252 sponsor respondents recognized that COVID-19 accelerated their adoption of decentralized clinical trials (or “DCT”) including wearable devices, protocol redesign, and investigator-facing technologies.  In May […]

The Challenges and Advantages of Decentralized Clinical Trials in an era of increasing complexities